CCND1 and lung cancer: Of these EBRs, only EBR-CCND1-(2) has an overlapping GR-binding region as observed in a GR ChIP-Seq study performed in a human lung cancer cell line (A549) treated with Dex (herein referred as GBR-CCND1) (43).